Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 2Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Colorectal Neoplasms 1432Pancreatic Neoplasms 860Carcinoma, Hepatocellular 743Stomach Neoplasms 647Colonic Neoplasms 447Rectal Neoplasms 404Esophageal Neoplasms 398Breast Neoplasms 331Carcinoma, Non-Small-Cell Lung 326Neoplasms 307Liver Neoplasms 282Cholangiocarcinoma 244Ovarian Neoplasms 243Lung Neoplasms 237Neoplasm Metastasis 235Gastrointestinal Neoplasms 217Melanoma 185Prostatic Neoplasms 166Esophageal Squamous Cell Carcinoma 166Biliary Tract Neoplasms 161Endometrial Neoplasms 143Uterine Cervical Neoplasms 130Squamous Cell Carcinoma of Head and Neck 129Carcinoma, Renal Cell 114Head and Neck Neoplasms 113Sarcoma 100Urinary Bladder Neoplasms 97Adenocarcinoma Of Esophagus 90Triple Negative Breast Neoplasms 86Anus Neoplasms 83

Interventions

Panitumumab 1IFL protocol 1Gemcitabine 1Cetuximab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytosis × Gastrointestinal × 1 year × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡